Catalyst4, Inc., 10% owner at MapLight Therapeutics, bought MPLT on Jul 28, 2026
Data as of Oct 16
- Traded
- Jul 28, 2026
- Disclosed
- Jul 30, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
MPLT since disclosure
−45.1%
Similar stocks (XLV) since disclosure
+8.1%
XLV — its sector index fund
Change in closing price from Jul 30, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$13Mdisclosed Jul 30 · filed the same day
- ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$37.9Kdisclosed Jul 30 · filed 1 day after the trade
- ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$761Kdisclosed Jul 30 · filed 2 days after the trade